Search results
Methicillin resistant Staphylococcus aureus infection, unspecified site. A49.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM A49.02 became effective on October 1, 2023.
29 lis 2023 · According to the European Committee on Antimicrobial Susceptibility Testing (EUCAST), S. aureus with oxacillin MIC values >2 mg/L are mostly methicillin resistant [2]. Issues related to treatment of skin and soft tissue infections in adults caused by MRSA will be reviewed here.
26 sie 2024 · This topic review discusses the signs and symptoms, diagnostic tests, treatment, and prevention of a particularly dangerous form of Staph aureus called methicillin-resistant Staphylococcus aureus (MRSA; pronounced "Mursa").
1 paź 2023 · A49.02 is a valid billable ICD-10 diagnosis code for Methicillin resistant Staphylococcus aureus infection, unspecified site. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024.
8 lis 2022 · Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a type of staph bacteria that's become resistant to many of the antibiotics used to treat ordinary staph infections.
31 maj 2024 · MRSA is a type of Staphylococcus aureus that is resistant to most beta-lactam antibiotics, antistaphylococcal penicillins (e.g., methicillin, oxacillin), and cephalosporins. Methicillin resistance is defined as an oxacillin minimum inhibitory concentration of ≥4 micrograms/mL. [1]
A49.02 is a billable diagnosis code used to specify a medical diagnosis of methicillin resistant staphylococcus aureus infection, unspecified site. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.
